42nd Annual CFS Preview for Integrative Care: The Show and After Show

As optimized testing and treatments for early and advanced cancers continue to improve clinical outcomes, the 42nd Annual Chemotherapy Foundation Symposium will help to educate those in the multidisciplinary approach to care.

In the next episode of The Show and After Show, co-hosts Kristie L. Kahl and Andrew Svonavec talk to program co-chair Benjamin P. Levy, MD, associate professor, Johns Hopkins School of Medicine, and clinical director of medical oncology, Johns Hopkins Sidney Kimmel Cancer Center, Sibley Memorial Hospital, about what to expect from attending the symposium, as well as places to visit and eat in New York City.

New to the symposium, CFS will add education for nurses and advanced practice providers with its own dedicated track. “That track is really going to be special. It's really looking at different topics, everything from managing toxicities of cellular therapies … and also managing toxicities of other drugs that are very commonly used in solid humor practice, but maybe a little nuance on how to manage those,” Levy explained. “I think some of the unique topics that I'm really excited about is one looking at subsets of patients, like the elderly, and how we manage toxicities in those patients.”

Levy added that the symposium will highlight education around antibody drug conjugates, diagnostics, novel targeted therapies, and more.

Additional learning objectives will:

• Compare the risks and benefits of treatment regimens based on recent clinical trials across solid and liquid tumors
• Apply strategies to identify and mitigate treatment-related adverse effects associated with solid and liquid tumor treatment approaches
• Incorporate individual patient and disease characteristics in treatment decisions to optimally manage solid and liquid tumors
• Determine optimal therapy based on biomarker testing across multiple solid and liquid tumors

CFS, to be held in New York City from November 13-15, 2024, will offer exciting new developments and rapid changes that continue to occur in the management of solid and hematologic malignancies. To learn more about CFS, or to register for the symposium, visit 42nd Annual CFS: Innovative Cancer Therapy for Tomorrow®.

This is just a taste of the wealth of information and inspiration waiting at the 42nd Annual CFS. Check back for future meeting previews with The Show and After Show.

Register for CFS now: https://event.gotoper.com/rX8KX0?RefId=CN_TSAS